30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q13 Revenue: MAKO Surgical

$22.8MM, -22%

  • Procedures $16.2MM, +35%
  • Systems $2.6MM, -81%
  • Service $3.8MM, +41%

 

Did not convene a conference call this quarter.

  • Four RIO systems sold (U.S. 2, Singapore 1, Taiwan 1)
  • Commercial installed base of RIO systems now 174 (U.S. 166)
  • Four MAKOplasty total hip arthroplasty (THA) applications sold (2 with new RIO systems, 2 upgrades)
  • 167 MAKOplasty sites worldwide
  • To date, 115 RIO systems have THA application
  • 3,259 MAKOplasty procedures performed, +35% (U.S. 3,152; THA 166, +119%; ex-U.S. 107)
  • Since launch, 33,000 MAKOplasty procedures performed to date
  • In 4Q, acquired from Pipeline Biomedical all business dedicated to orthopaedic devices and instruments for use with robotic devices/manual medical procedures for $2.5MM plus ~4MM shares